American Medical Electronics
This article was originally published in The Gray Sheet
Executive Summary
Dallas-based manufacturer of bone healing products signs letter of intent to acquire Advanced Spine Fixation Systems. According to the terms of the agreement, AME will issue 2.5 mil. shares of its stock (worth about $20.6 mil. based on Aug. 22 closing price of 8-1/4 per share) in exchange for all outstanding shares of ASFS. Cypress, California-based ASFS, which had first half sales of about $4 mil., was going to be acquired by Wright Medical, but talks broke down ("The Gray Sheet" Aug. 15, In Brief). "The addition of the ASFS product lines...will allow the company to substantially broaden the products it offers to the worldwide spinal fixation market," AME says
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.